Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
JAZZ

Market Cap: $15.44B

JP

Jazz Pharmaceuticals plc

JAZZ

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin84.67%

EBITDA Margin32.09%

EBIT Margin20.04%

Pre-tax Margin15.81%

Net Profit Margin20.45%

Earnings Yield6.06%

Valuation Multiples

Price / Book3.24

Price / Sales3.36

Price / Earnings16.17

PEG0.00

Forward PEG4.76

EV / Sales3.96

EV / EBITDA12.35

EV / Operating Cash Flow10.98

EV / Free Cash Flow11.82

Price / Free Cash Flow10.01

Price / Operating Cash Flow9.35

Cash Flow & Capital

Free Cash Flow / Share$24.4

Operating Cash Flow / Share$26.28

Free Cash Flow Yield9.99%

Capex / Revenue2.58%

Capex / Operating Cash Flow7.15%

Capex / Depreciation0.11

Stock Compensation / Revenue9.47%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.78

Quick Ratio1.58

Cash Ratio0.73

Debt / Assets0.40

Debt / Capital0.48

Debt / Equity0.92

Long-Term Debt / Capital0.41

Debt / Market Cap28.18%

Net Debt / EBITDA1.89

Solvency Ratio0.24

Financial Leverage2.31

Efficiency & Working Capital

Asset Turnover0.42

Fixed Asset Turnover17.42

Inventory Turnover1.59

Receivables Turnover5.22

Payables Turnover5.49

Days Sales Outstanding69.88

Days Inventory Outstanding229.29

Days Payables Outstanding66.51

Operating Cycle299.17

Cash Conversion Cycle232.66

Working Capital Turnover2.26

Returns & Quality

Return on Equity21.37%

Return on Assets8.49%

Return on Invested Capital14.46%

ROCE16.14%

Return on Tangible Assets17.91%

Operating Return on Assets12.46%

Income Quality-9.99

Tax Burden1.29

Interest Burden0.79

Balance Sheet & Intrinsic Metrics

Enterprise Value$18.23B

Invested Capital$7.83B

Working Capital$1.74B

Tangible Asset Value$-1.03B

Net Current Asset Value$-2.31B

Graham Number$159.52

Graham Net-Net-$50.59

Book Value / Share$75.98

Tangible Book Value / Share-$16.26

Cash / Share$34.81

Financial Health Scores

Piotroski Score8

Altman Z-Score2.46

Revenue$4.6B

EBIT$921.9M

Market Cap$15.11B

Working Capital$1.74B

Retained Earnings$1.13B

Total Assets$11.08B

Total Liabilities$6.28B